However our findings on the role of a wild type DDHD domain in preventing retinal degeneration provide an insight into the cellular mechanisms that could explain the neurodegenerative phenotype seen in spastic paraplegias, in patients carrying mutations in human DDHD1 and DDHD2. The gene discussed is DDHD2; the disease is Spastic paraplegia.